CSF Somatostatin in alzheimer's disease, depressed patients, and control subjects

1988 ◽  
Vol 24 (6) ◽  
pp. 710-712 ◽  
Author(s):  
Kenneth L. Davis ◽  
Michael Davidson ◽  
Ren-Kui Yang ◽  
Bonnie M. Davis ◽  
Larry J. Siever ◽  
...  
2011 ◽  
Vol 31 (6) ◽  
pp. 413-416 ◽  
Author(s):  
Christoph Laske ◽  
Andreas J. Fallgatter ◽  
Elke Stransky ◽  
Katja Hagen ◽  
Daniela Berg ◽  
...  

1994 ◽  
Vol 51 (3) ◽  
pp. 260-268 ◽  
Author(s):  
T. Erkinjuntti ◽  
F. Gao ◽  
D. H. Lee ◽  
M. Eliasziw ◽  
H. Merskey ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shun-Ku Lin ◽  
Hsin Hsiu ◽  
Hsi-Sheng Chen ◽  
Chang-Jen Yang

AbstractCerebrovascular atherosclerosis has been identified as a prominent pathological feature of Alzheimer’s disease (AD); the link between vessel pathology and AD risk may also extend to extracranial arteries. This study aimed to determine the effectiveness of using arterial pulse-wave measurements and multilayer perceptron (MLP) analysis in distinguishing between AD and control subjects. Radial blood pressure waveform (BPW) and finger photoplethysmography signals were measured noninvasively for 3 min in 87 AD patients and 74 control subjects. The 5-layer MLP algorithm employed evaluated the following 40 harmonic pulse indices: amplitude proportion and its coefficient of variation, and phase angle and its standard deviation. The BPW indices differed significantly between the AD patients (6247 pulses) and control subjects (6626 pulses). Significant intergroup differences were found between mild, moderate, and severe AD (defined by Mini-Mental-State-Examination scores). The hold-out test results indicated an accuracy of 82.86%, a specificity of 92.31%, and a 0.83 AUC of ROC curve when using the MLP-based classification between AD and Control. The identified differences can be partly attributed to AD-induced changes in vascular elastic properties. The present findings may be meaningful in facilitating the development of a noninvasive, rapid, inexpensive, and objective method for detecting and monitoring the AD status.


1991 ◽  
Vol 30 (5) ◽  
pp. 686-693 ◽  
Author(s):  
Hiroyuki Arai ◽  
Virginia M.-Y. Lee ◽  
Meridith L. Messinger ◽  
Barry D. Greenberg ◽  
David E. Lowery ◽  
...  

NeuroImage ◽  
2010 ◽  
Vol 52 ◽  
pp. S186-S187
Author(s):  
Masanori Ichise ◽  
Geog Becker ◽  
Barthel Henryk ◽  
Marianne Patt ◽  
Julia Luthardt ◽  
...  

Author(s):  
Orietta Miatto ◽  
R. Gilberto Gonzalez ◽  
Ferdinando Buonanno ◽  
John H. Growdon

Abstract:In order to study possible metabolic derangements in Alzheimer's disease (AD), we performed phosphorus 31 nuclear magnetic resonance (31P NMR) spectroscopy on brain samples obtained at autopsy from 7 patients with AD and 9 control subjects. Aqueous solutions of brain tissue contained well-defined peaks of intermediate compounds in phospholipid metabolism, including the phosphomonoesters phosphocholine and phosphoethanolamine, and the phosphodiesters glycerophosphorylcholine and glycerophosphorylethanolamine. 3IP NMR spectra also displayed the inorganic phosphorus signal, which provides an index to the in vivo concentration of high-energy compounds.We found evidence for altered phospholipid metabolism in that relative levels of phosphomonoesters were decreased, and phosphodiesters increased, in frontal and parietal regions of patients with AD compared to control subjects. The inorganic phosphorus resonance peaks were similar in AD and control subjects, suggesting that energy stores are not diminished in AD. These preliminary data are consistent with the hypothesis that abnormalities in phospholipid metabolism contribute to possible neuronal membrane dysfunction and impaired cholinergic neurotransmission in AD.


Sign in / Sign up

Export Citation Format

Share Document